Sai Rangarao - Jul 2, 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (PTHS)

Role: Chief Commercial Officer
Signature: /s/ Sai Rangarao
Stock symbol: PTHS
Transactions as of: Jul 2, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/21/2025, 08:26 PM
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rangarao Sai	Chief Commercial Officer	C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM	/s/ Sai Rangarao	2025-07-21	0002077227

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTHS	Restricted Stock Units	Award		+30.5K			30.5K	Jul 2, 2025	Common Stock	30.5K	$13.50	Direct	F1
transaction	PTHS	Stock Option	Award		+93K			93K	Jul 2, 2025	Common Stock	93K	$13.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 30,518 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2	On July 2, 2025, the Reporting Person was granted stock options to purchase 93,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.